Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Blankenstein, Thomas Prof. Dr. (1) Cakmak-Görür, Nese Dr. (1) Dörr, Jan Rafael (1) Haas, Simon Dr. rer. nat. (3) Holz, Maximilian (1) Höpken, Uta Elisabeth PD Dr. (1) Horne, Arik (1) Janz, Martin Dr. (5) Kempa, Stefan Dr. (1) Mathas, Stephan Dr. (4) Mertins, Philipp Dr. (2) Na, Il-Kang Dr. (3) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (8) Popp, Oliver Dr. (1) Rhein, Simone Dr. (2) Schmitt, Clemens Prof. Dr. (2) Solé Boldo, Llorenc Dr. rer. nat. (1) Strzelecka, Paulina Maria (1) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (1) Yousefian, Schayan (2) (-) Keller, Ulrich Dr. med. (85) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2019 (1) 2020 (11) 2021 (18) 2022 (19) 2023 (19) 2024 (10) Advanced Light Microscopy (1) Animal Phenotyping (1) Biobank (1) Bioinformatics and Omics Data Science (9) Biology of Malignant Lymphomas (9) Cancer Genetics and Cellular Stress Responses (4) Computational Regulatory Genomics (4) Developmental Biology / Signal Transduction (1) Developmental Neurobiology (1) Development and Function of Neural Circuits (1) Epigenetic Modifications in Neuroblastoma (3) Epigenetic Regulation and Chromatin Architecture (1) Flow Cytometry (1) Gastrointestinal Barrier, Regeneration and Carcinogenesis (1) Genomics (1) Immune Dysregulations in Oncology (3) Immune Regulation and Cancer (3) Intracellular Proteolysis (1) Mathematical Modelling of Cellular Processes (3) (-) Mechanism-based Cancer Therapies (85) Microenvironmental Regulation in Autoimmunity and Cancer (2) Mobile DNA (1) Molecular and cellular basis of behavio (1) Molecular Cardiovascular Research (1) Molecular Epidemiology (1) Molecular Immunology and Gene Therapy (4) Molecular Pathways in Cortical Development (1) Molecular Physiology of Somatic Sensation (13) Neural Circuits and Behaviour (2) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (2) Organoids (1) Pluripotent Stem Cells (1) Protein Production and Characterization (2) Proteome Dynamics (4) Proteomics (5) Proteomics and Metabolomics (33) Quantitative Developmental Biology (1) RNA Biology and Posttranscriptional Regulation (7) Systems Biology Imaging (1) Systems Biology of Gene Regulatory Elements (7) Systems Hematology, Stem Cells & Precision Medicine (3) Translational Bioinformatics (4) Translational Cardiology and Functional Genomics (1) Translational Oncology of Solid Tumors (189) Translational Tumorimmunology (1) Tumor heterogeneity and treatment resistance in pediatric cancer (1) 85 Results: Active Filter: Keller, Ulrich Dr. med.Mechanism-based Cancer Therapies Sort: Result score Newest to oldest Oldest to newest April 01, 2022 / Acta Neurol Belg A peculiar case of primary central nervous system T-cell lymphoma with indolent behavior D. Wasilewski M. Janz A. Koch A. Rosenwald U. Keller P. Vajkoczy K. Faust I. Anagnostopoulos J. Radke June 01, 2022 / Ann Hematol Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis K. Braitsch A. Schwarz K. Koch M. Hubbuch H. Menzel U. Keller K.S. Götze F. Bassermann P. Herhaus M. Verbeek April 01, 2022 / Br J Haematol A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial G. Hess A. Hüttmann M. Witzens-Harig M.H. Dreyling U. Keller R. Marks T. Ernst C. Pott A. Viardot F. Frontzek M. Trautmann C. Ruckes O. Deuster A. Rosenwald M. Theobald G. Lenz April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse May 02, 2022 / J Clin Invest Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer U.M. Demel M. Böger S. Yousefian C. Grunert L. Zhang P.W. Hotz A. Gottschlich H. Köse K. Isaakidis D. Vonficht F. Grünschläger E. Rohleder K. Wagner J. Dönig V. Igl B. Brzezicha F. Baumgartner S. Habringer J. Löber B. Chapuy C. Weidinger S. Kobold S. Haas A.B. Busse S. Müller M. Wirth M. Schick U. Keller September 01, 2022 / HemaSphere Genotype and intensive pretreatment influence outcome of acute myeloid leukemia patients treated with venetoclax in combination with hypomethylating agents or low-dose cytarabine: "real world" data from germany K. Braitsch L.K. Schmalbrock P. Jung I. Bumeder P. Kiewe J.S. Hecker M. Verbeek J. Westermann L. Bullinger U. Keller F. Bassermann J. Krönke K.S. Götze K. Rieger July 01, 2022 / Leukemia Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial A.J.M. Ferreri K. Cwynarski E. Pulczynski C.P. Fox E. Schorb C. Celico M. Falautano A. Nonis P. La Rosée M. Binder A. Fabbri F. Ilariucci M. Krampera Al. Roth C. Hemmaway P.W. Johnson K.M. Linton T. Pukrop J.S. Gørløv M. Balzarotti G. Hess U. Keller S. Stilgenbauer J. Panse A. Tucci L. Orsucci F. Pisani M. Zanni S.W. Krause H.J. Schmoll B. Hertenstein M. Rummel J. Smith L. Thurner G. Cabras E. Pennese M. Ponzoni M. Deckert L.S. Politi J. Finke A. Ferranti K. Cozens E. Burger N. Ielmini F. Cavalli E. Zucca G. Illerhaus February 28, 2023 / Blood Adv SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma G.J.J.E. Heynen F. Baumgartner M. Heider U. Patra M. Holz J. Braune M. Kaiser I. Schäffer S.A. Bamopoulos E. Ramberger A. Murgai Y.L.D. Ng U.M. Demel D. Laue S. Liebig J. Krüger M. Janz A. Nogai M. Schick P. Mertins S. Müller F. Bassermann J. Krönke U. Keller M. Wirth October 01, 2021 / Leukemia CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness R. Lewis H.C. Maurer N. Singh I. Gonzalez-Menendez M. Wirth M. Schick L. Zhang K. Isaakidis A.K. Scherger V. Schulze J. Lu T. Zenz K. Steiger R. Rad L. Quintanilla-Martinez M. Espeli K. Balabanian U. Keller S. Habringer January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next › Last page Last »
April 01, 2022 / Acta Neurol Belg A peculiar case of primary central nervous system T-cell lymphoma with indolent behavior D. Wasilewski M. Janz A. Koch A. Rosenwald U. Keller P. Vajkoczy K. Faust I. Anagnostopoulos J. Radke
June 01, 2022 / Ann Hematol Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis K. Braitsch A. Schwarz K. Koch M. Hubbuch H. Menzel U. Keller K.S. Götze F. Bassermann P. Herhaus M. Verbeek
April 01, 2022 / Br J Haematol A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial G. Hess A. Hüttmann M. Witzens-Harig M.H. Dreyling U. Keller R. Marks T. Ernst C. Pott A. Viardot F. Frontzek M. Trautmann C. Ruckes O. Deuster A. Rosenwald M. Theobald G. Lenz
April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse
May 02, 2022 / J Clin Invest Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer U.M. Demel M. Böger S. Yousefian C. Grunert L. Zhang P.W. Hotz A. Gottschlich H. Köse K. Isaakidis D. Vonficht F. Grünschläger E. Rohleder K. Wagner J. Dönig V. Igl B. Brzezicha F. Baumgartner S. Habringer J. Löber B. Chapuy C. Weidinger S. Kobold S. Haas A.B. Busse S. Müller M. Wirth M. Schick U. Keller
September 01, 2022 / HemaSphere Genotype and intensive pretreatment influence outcome of acute myeloid leukemia patients treated with venetoclax in combination with hypomethylating agents or low-dose cytarabine: "real world" data from germany K. Braitsch L.K. Schmalbrock P. Jung I. Bumeder P. Kiewe J.S. Hecker M. Verbeek J. Westermann L. Bullinger U. Keller F. Bassermann J. Krönke K.S. Götze K. Rieger
July 01, 2022 / Leukemia Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial A.J.M. Ferreri K. Cwynarski E. Pulczynski C.P. Fox E. Schorb C. Celico M. Falautano A. Nonis P. La Rosée M. Binder A. Fabbri F. Ilariucci M. Krampera Al. Roth C. Hemmaway P.W. Johnson K.M. Linton T. Pukrop J.S. Gørløv M. Balzarotti G. Hess U. Keller S. Stilgenbauer J. Panse A. Tucci L. Orsucci F. Pisani M. Zanni S.W. Krause H.J. Schmoll B. Hertenstein M. Rummel J. Smith L. Thurner G. Cabras E. Pennese M. Ponzoni M. Deckert L.S. Politi J. Finke A. Ferranti K. Cozens E. Burger N. Ielmini F. Cavalli E. Zucca G. Illerhaus
February 28, 2023 / Blood Adv SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma G.J.J.E. Heynen F. Baumgartner M. Heider U. Patra M. Holz J. Braune M. Kaiser I. Schäffer S.A. Bamopoulos E. Ramberger A. Murgai Y.L.D. Ng U.M. Demel D. Laue S. Liebig J. Krüger M. Janz A. Nogai M. Schick P. Mertins S. Müller F. Bassermann J. Krönke U. Keller M. Wirth
October 01, 2021 / Leukemia CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness R. Lewis H.C. Maurer N. Singh I. Gonzalez-Menendez M. Wirth M. Schick L. Zhang K. Isaakidis A.K. Scherger V. Schulze J. Lu T. Zenz K. Steiger R. Rad L. Quintanilla-Martinez M. Espeli K. Balabanian U. Keller S. Habringer
January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt